Keyomics Limited, London
Keyomics Limited is a private limited company. Registered at Cumberland House (Suite 602), 80 Scrubs Lane, London NW10 6RF, the aforementioned 2 years old firm was incorporated on 2021-06-22 and is officially categorised as "other human health activities" (SIC: 86900).1 director can be found in the firm: Christopher M. (appointed on 22 June 2021).
| About | |
|---|---|
| Name: Keyomics Limited | |
| Number: 13470580 | |
| Incorporation date: 2021-06-22 | |
| End of financial year: 30 June |
| Address: |
Cumberland House (suite 602) 80 Scrubs Lane London NW10 6RF |
| SIC code: |
86900 - Other human health activities |
Company staff
People with significant control
Affinity Laboratories Limited
22 June 2021
| Address | 51a Davenant Road, London, N19 3NW, England |
| Legal authority | Companies Act 2006 |
| Legal form | Private Company Limited By Shares |
| Country registered | United Kingdom |
| Place registered | Uk Register Of Companies |
| Registration number | 10566588 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Financial data
| Date of Accounts | 2022-06-30 |
| Current Assets | 100 |
| Total Assets Less Current Liabilities | 100 |
The due date for Keyomics Limited confirmation statement filing is 2024-07-05. The most current confirmation statement was filed on 2023-06-21. The deadline for a subsequent statutory accounts filing is 31 March 2024. Latest accounts filing was submitted for the time period up until 30 June 2022.
1 person of significant control is indexed in the Companies House, an only company Affinity Laboratories Limited that has over 3/4 of shares, 3/4 to full of voting rights. The corporate PSC can be reached at Davenant Road, N19 3NW London.
Company filing
Filter filings by category:
Accounts
Address
Confirmation statement
Gazette
Incorporation
| Type | Free download | |
|---|---|---|
| DISS40 |
Compulsory strike-off action has been discontinued filed on: 30th, September 2023 | gazette |
Free Download
(1 page)
|